Navigation Links
Pivotal Phase 3 Study Published in The New England Journal of Medicine (NEJM) Finds Overall Survival of Patients with Metastatic Castration-Resistant Prostate Cancer is Significantly Improved with ZYTIGA™ (abiraterone acetate)
Date:5/25/2011

HORSHAM, Pa., May 25, 2011 /PRNewswire/ -- A study titled "Abiraterone and Increased Survival in Metastatic Prostate Cancer," published in the May 26 issue of NEJM, found that patients with metastatic castration-resistant prostate cancer who have received prior chemotherapy containing docetaxel showed a significant improvement in overall survival when treated with ZYTIGA(abiraterone acetate) plus prednisone compared to patients treated with prednisone plus placebo.  The COU-AA-301 study was sponsored by Ortho Biotech Oncology Research & Development, unit of Cougar Biotechnology, Inc.

Results of the pivotal Phase 3, randomized, placebo-controlled, multicenter study showed that at pre-specified interim analysis, treatment with ZYTIGA in combination with prednisone resulted in a 35.4 percent reduction in the risk of death (14.8 months vs. 10.9 months [hazard ratio (HR) = 0.65; 95 percent CI: 0.54, 0.77; p<0.001]) and a 3.9 month difference in median survival compared to placebo plus prednisone.

The most common adverse events identified by the authors were fatigue, back pain, nausea, constipation, bone pain and arthralgia, which occurred at similar frequency in both arms.  Urinary tract infections were more frequent in the ZYTIGA arm.  Adverse events associated with elevated mineralocorticoid levels due to CYP17 inhibition (fluid retention and edema, hypokalemia and hypertension), as well as cardiac disorders and liver-function test abnormalities were deemed of special interest and were more common in the ZYTIGA arm.  Additional information is included in the Important Safety Information below.

"Given that men with metastatic castration-resistant prostate cancer have few options, we are pleased with the results of this rigorous study, which show that abiraterone acetate may extend survival in these patients," said Johann S. de Bono, MD, FRCP, MSc, PhD, The Institute for Cancer Research, The Royal
'/>"/>

SOURCE Centocor Ortho Biotech Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
3. Positive Kuvan(TM) Pivotal Phase 3 Trial Results Published in The Lancet
4. Genzyme Announces Second Pivotal Mozobil Trial Meets Primary Endpoint
5. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
6. CryoCor Completes Enrollment of Pivotal Clinical Study for Atrial Fibrillation
7. Cadence Pharmaceuticals Completes Enrollment of Pivotal Phase III Trial for Intravenous Acetaminophen Ahead of Schedule
8. Kosan Receives Completed Special Protocol Assessment for TIME-1 Pivotal Phase 3 Trial of Tanespimycin in Multiple Myeloma
9. Sucampo Pharmaceuticals, Inc. Begins Pivotal Phase III Studies of Oral Lubiprostone to Treat Opioid-Induced Bowel Dysfunction (OBD)
10. Interim Response and Safety Analyses Support Continuation of Allos Therapeutics Pivotal Phase 2 PROPEL Trial of PDX in Patients with Peripheral T-Cell Lymphoma
11. Arbios Provides Clinical Strategy for SEPET(TM) Pivotal Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... July 31, 2014  Decision Resources Group,s ... about by the Affordable Care Act (ACA), ... of pharmaceutical therapies. The ACA altered how ... new regulations and expanded access via government-supported ... health exchanges—state-based marketplaces set up by states ...
(Date:7/31/2014)... 2014  A substantial share of pharmacy and ... therapies are included in formularies—say patient support resources ... new Manhattan Research study, Taking the Pulse® ... that P&T committee members in hospitals, managed care ... set a high bar for these programs, requiring ...
(Date:7/31/2014)... -- Lazarus Effect, a medical device company focused on ... of blood clots, announced the closing of a $5 ... commercialization of several approved Lazarus Effect devices, as well ... Cover™ in the United States . ... value of our novel, platform technology as well as ...
Breaking Medicine Technology:Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 2Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 3Health Exchanges Drive Change In MCO Strategies And Physician Prescribing Decisions; Impact On Pharma Mixed 4Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 2Formulary Decision Makers Say Pharma-Provided Patient Support Solutions Influence Formulary Placement 3Lazarus Effect Closes $5 Million Financing 2
... FRISCO, Texas, March 15, 2012  OxySure® Systems, Inc. ... easy-to-use emergency oxygen solutions with its "oxygen from ... into a Supplier Agreement ("Agreement") with W.W. Grainger, ... (Logo:  http://photos.prnewswire.com/prnh/20120315/DA71084LOGO ) In ...
... According to a national survey of independent pharmacists, ... drugstores and consumers who changed pharmacies. Independent pharmacists say ... ease, and still have many choices despite the absence ... This survey reveals significant upsides to preferred pharmacy ...
Cached Medicine Technology:OxySure Systems Announces Supplier Agreement With Grainger 2OxySure Systems Announces Supplier Agreement With Grainger 3New Survey: Walgreens' Customers Flock to Independent Pharmacies 2
(Date:7/31/2014)... 2014) If you have asthma, you may have an ... you recognize and respond to changes and understand when symptoms ... the green zone, you,re doing well, yellow means your asthma ... require urgent care. New guidelines are now available to help ... into green and away from the red zone. , "Management ...
(Date:7/31/2014)... 31, 2014 Leelanau Peninsula’s newest winery, ... 2014 at 7788 East Horn Road in Lake Leelanau. Joining ... , Aurora Cellars is the 25th winery along the trail. ... popular wine tour events, making its trail event debut during ... , Owners David and Faye Mathia opened the boutique ...
(Date:7/31/2014)... Las Vegas, NV (PRWEB) July 31, 2014 ... personal trainer Tyler Bramlett and physical therapist expert Dr. James ... to shrink waistlines, fix back pain, relieve digestive issues, tone ... abs through a specific sequence of core exercises used to ... , After a quick 0-6 Pack Abs ...
(Date:7/31/2014)... FL (PRWEB) July 31, 2014 ... hospitals in the U.S. including Florida Hospital Tampa, ... Acute Care, Florida Hospital North Pinellas, Florida Hospital ... Medical Center Sebring, Florida Hospital Heartland Medical Center ... & Health Networks list of Most Wired Hospitals ...
(Date:7/31/2014)... Cosmetic Town has introduced a secure verification ... will be able to verify their patients before the ... guarantees their authenticity. This will help prospective patients ... information that has been verified to come from a ... Town to filter out fake patients who leave fraudulent ...
Breaking Medicine News(10 mins):Health News:Aurora Cellars Joins the Leelanau Peninsula Wine Trail 2Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 2Health News:Zero To Six Pack Abs System Review Exposes Tyler Bramlett And Dr. James Veghers’ New Ab Training Program 3Health News:Florida Hospital West Florida Region is Among the Most Wired Hospitals and Health Systems in the United States 2Health News:Cosmetic Town Improves Patient Experience Through Secure Verification of Patients and Doctors 2
... UPMC Health Plan announced it has,expanded both its ... its UPMC for Life Specialty Plan into Cameron, ... also announced the,expansion of its Medicare PPO (Preferred ... our footprint in Western Pennsylvania helps us continue ...
... poor physical function, , , TUESDAY, Jan. 22 (HealthDay News) -- If ... have a greater risk of declining physical function as you age, ... researchers report that people with the lowest blood levels of vitamin ... physical function when compared to people with the highest levels of ...
... STERIS Corporation,(NYSE: STE ) today announced that ... in the amount of $0.06 per common share. The,dividend ... at the close,of business on February 12, 2008., ... to provide a healthier today and,safer tomorrow through knowledgeable ...
... International effort should spot genes that help cause disease, ... The genomes of 1,000 people worldwide will be ... and medically relevant look at human genetic variation ever ... researchers on Tuesday, the 1000 Genomes Project will receive ...
... from the Monell Center and Tokyo University of Agriculture ... compounds from common foods that activate human bitter taste ... Biochemical and Biophysical Research Communications, provide a practical means ... in particular. , Identification of bitter taste ...
... nanotechnology, scientists from UCLA and Northwestern University have ... that is invisible to the immune system, a ... treatments for cancer and other diseases. , The ... ACS Nano, provides an example of the enormous ...
Cached Medicine News:Health News:UPMC Health Plan Expands Medicare and Special Needs Plan Into Additional Western Pennsylvania Counties 2Health News:Lack of Vitamin E Linked to Physical Decline 2Health News:Lack of Vitamin E Linked to Physical Decline 3Health News:STERIS Corporation Declares Regular Quarterly Dividend 2Health News:STERIS Corporation Declares Regular Quarterly Dividend 3Health News:Project Will Map Genomes of 1,000 People Worldwide 2Health News:Food peptides activate bitter taste receptors 2Health News:Scientists use nanomaterials to localize and control drug delivery 2Health News:Scientists use nanomaterials to localize and control drug delivery 3
... INVACARE CHECK 02 PLUS CONCENTRATOR ANALYZER ... reports all the operating parameters necessary for ... O2 Plus ™, an efficient and cost-effective ... checks oxygen concentration (%), flow rate (L-min), ...
... the new Platinum 10 concentrator. The Platinum ... advantage you have come to expect from ... an attractive alternative to liquid systems. The ... 10 LPM for high flow patients, and ...
... QuietLife 5 Oxygen Concentrator is a low ... continuous flow oxygen for prescriptions up to ... the quietest running concentrator at <40 dBA, ... or caregivers. Concentrators are also an economical ...
... AirSep's LifeStyle Portable Oxygen Concentrator is ... At less than 10 lbs (4.5 kg), ... traveling, working, and highly active oxygen patient., ... and combining the technologies of both an ...
Medicine Products: